UNSPSC 51142503: Levodopa

This classification denotes a dopamine agonist with the molecular formula C9H11NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 46627O600J, chemically known as 3,4-dihydroxyphenyl-l-alanine but generally known as levodopa, which bears US NIH Compound Identifier 836. European Medicines Agency schedules Levodopa in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08468MIG.

UNSPSC 51142503 Levodopa is a Commodity code intended for pharmaceutical procurement, but the recent state and local solicitation activity posted under this code does not involve levodopa or any pharmaceutical products in their conventional sense. Instead, the City of Tucson is soliciting athletic training services for fire and police departments, and the City of Tampa is requesting medical aid supplies including first-aid items, bandages, and over-the-counter medications such as aspirin and pain relievers—a mismatch between the code's nominal scope and the work actually being bought. The Texas Health and Human Services Commission issued a Request for Information on a direct-to-manufacturer prescription program, which touches on pharmaceutical procurement but is exploratory market research rather than a concrete goods solicitation. The code shows little relevant recent activity aligned with levodopa specifically; the opportunities tagged to it appear to reflect broader medical supply, first-aid, and pharmacy-benefit procurement that the issuing bodies have categorized under this commodity code.

The geographic spread of recent activity includes Arizona, Florida, and Texas, with the City of Tucson posting an RFP for athletic training services due June 9, 2026, and the City of Tampa posting an ITB for medical aid supplies (with a bid opening originally scheduled for April 9, 2025, though the posting date is April 24, 2026, suggesting a potential notice refresh or data inconsistency). The Texas HHS Commission's RFI closed April 3, 2026, and serves as preliminary market research rather than a formal procurement vehicle. Issuing bodies include city fire rescue and police departments and a state health agency. Given the mismatch between the code's pharmaceutical scope and the actual work being solicited, firms pursuing opportunities under this code should clarify with procurement offices whether their pharmaceutical product lines or pharmacy services align with the intended commodity, or whether the code assignment reflects a data-entry variance that should be corrected before proposal submission.